CDRD is a proud sponsor of the TAT11 International Symposium on targeted alpha therapy hosted by Canadian Nuclear Laboratories. We are excited to be co-hosting a panel discussion “The Renaissance of Radio Pharmaceuticals – A Commercial Perspective”. Stay tuned for a big announcement in this field!